T. Rowe Price's Q1 holdings report came out about 1/2 hour ago, and looking it over I don't see any SONS shares (could have missed them). IF they no longer have SONS, that would imply that they sold 1,224,528 shares of SONS in Q1.
They're showing 1,013,172 shares, up from 527,489 shares. My thesis that one or more of the big 'tute holders bailed last quarter is now in question, but we've still got a few to go...
Dimensional's HR for Q1 is just out, and they show 1,901,383 shares of SONS as of 3/31 as compared to their 12/31 holding of 1,641,624 shares. They added 342,192 shares in Q4, so they've added 600K shares in the last 2 quarters.
Vanguard's holdings report came out this morning, and it shows they held 1,980,706 MLNK shares as of 3/31. This compares to 1,541,034 they held at the end of last year, so they've added almost 440K.
Just now looking thru the 10Q for the cash & equiv. number, I came across this little tidbit:
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2):
194,600 Average Price Paid per Share - $7.37
I'm also looking to see what kind of NOL SONS has - that could be a big factor in a merger.
Maybe the reason for wanting to "re-value" the company stock options??
Also, from the recent 10Q:
Our cash, cash equivalents, and short- and long-term investments totaled $142.4 million at March 31, 2016
So, if there is an offer @ $600M, wouldn't Genband's net cost be $457.6M?
I haven't checked in on the MLNK board for a while, but I see we have at least a little active thought going on around here. As to class-action suits, my experience with them is that certain law firms seem to file them at the drop of a hat & shareholders seldom get much benefit from them.
When Steel & HNH came on the scene, I thought we'd finally see someone take advantage of MLNKs huge NOL carryforwards, but that hasn't yet been the case. In fact, the share price here has fallen from the $4 range to the present $1.45 in the last 2 years. As #$%$ pointed out, they took a big hit when a large customer left. There are other factors at work here too. MLNK is in a low-margin business. The stock being so closely held keeps daily trading volume very low (and possibly easy to manipulate). Steel Partners evidently had a setback in one of their other holdings and there may be fear of contagion. As anyone who has followed the company knows, there is an almost total lack of communication with the retail shareholders, which doesn't do much for investor interest. HNH/Steel has been moving VERY slowly on a possible acquisition, and Steel's Lichtenstein has been profiled rightly or wrongly as someone who takes a long view on investments.
At this point, I'm frustrated, but holding to see what happens. I try to never give investment advice to anyone, but try to report if I find any news on one of my holdings. In that vein, today I noticed that Medifast's share price hit a new 52-week high @ $34.72. Last report I saw, MLNK still had 577,149 shares, but that put them at 4.9% of MED shares o/s, so the reporting requirements have changed.
Just for old times sake. I think this number came out last night:
And, looking at the trend over the last several months, the shorts have clearly been using the low share price to cover:
Sorry, meant SDN. Where did SDC come from?
btw, I looked at my SONS July $5 call options, and it appears that I control the open interest. LOL!
You can read it under MLNK headlines. Yahoo has deleted several posts that I made trying to refer to it. I'm not a big fan of theirs, and the guy doesn't seem to know about Steel Partners' holdings.
ModusLink Global Solutions™, Inc. (the “Company”) (MLNK) today announced that its Board of Directors has appointed Warren G. Lichtenstein as its interim Chief Executive Officer, replacing John J. Boucher who resigned as President and Chief Executive Officer on March 23, 2016 to pursue other interests. Mr. Lichtenstein will remain Chairman of the Board. The Company also disclosed today that James R. Henderson has been appointed as the Chief Executive Officer of the Company’s principal operating subsidiary, ModusLink Corporation (“ModusLink”).
“Jim is an experienced business executive with an impressive track record in sales, operations and supply chain management,” stated Mr. Lichtenstein. “I’ve worked with Jim for years and his knowledge of our industry and the markets we serve, along with his extensive hands-on operational experience, make him the perfect fit to lead ModusLink in this important period in our corporate evolution. We have the cash resources on hand to grow our core business and enhance operational capabilities. On behalf of the Board, I would like to welcome Jim to ModusLink and look forward to collaborating with him as we continue to execute our strategy while driving long-term shareholder value.”
So far, "executing our strategy" has indeed been "driving long-term shareholder value", but in the wrong direction. Let's hope that this latest change signals a reversal of that trend.
This is like Chinese water torture. Recall the article posted here sometime back that said that the Steel Partners Lichtenstein took a long-term approach.
Medifast's earnings were out yesterday, and the stock took a beating this morning. It's bounced back from the $27.62 it hit, now trading close to $29, but still down about $1.80. This will affect MLNK's position in the stock, but I'm wondering if it also might give some impetus to some of the big stakeholders who have been pushing for a change.
Meanwhile, MLNK is doing pretty much what I expected, NOT releasing their earnings report until the last possible moment. GLTA
I just counted the days out on my calendar, and looks like 40 days from the end of MLNK's Jan31 quarter would be March 11 - tomorrow. There's nothing stopping them from releasing the figures sooner, but based on past performance, my guess is we'll see them at the last possible moment. GLTA